IL165398A0 - Method for identifying immunoreactive peptides - Google Patents
Method for identifying immunoreactive peptidesInfo
- Publication number
- IL165398A0 IL165398A0 IL16539803A IL16539803A IL165398A0 IL 165398 A0 IL165398 A0 IL 165398A0 IL 16539803 A IL16539803 A IL 16539803A IL 16539803 A IL16539803 A IL 16539803A IL 165398 A0 IL165398 A0 IL 165398A0
- Authority
- IL
- Israel
- Prior art keywords
- peptides
- immunoreactive peptides
- identifying
- tumorous
- identifying immunoreactive
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to a method for identifying immunoreactive peptides. According to said method, a sample consisting of tumorous and corresponding healthy tissue is first prepared, the tumour-specific expression profile is subsequently determined and antigenic peptides are isolated from the tumorous tissue and analysed. The respective data that has been obtained is then matched and peptides are identified on the basis of said matched data.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10225139A DE10225139A1 (en) | 2002-05-29 | 2002-05-29 | Methods for the identification of immunoreactive peptides |
| PCT/EP2003/005038 WO2003100432A2 (en) | 2002-05-29 | 2003-05-14 | Method for identifying immunoreactive peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL165398A0 true IL165398A0 (en) | 2006-01-15 |
Family
ID=29557590
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16539803A IL165398A0 (en) | 2002-05-29 | 2003-05-14 | Method for identifying immunoreactive peptides |
| IL165398A IL165398A (en) | 2002-05-29 | 2004-11-25 | Method for identifying immunoreactive peptides |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL165398A IL165398A (en) | 2002-05-29 | 2004-11-25 | Method for identifying immunoreactive peptides |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1508047B1 (en) |
| JP (1) | JP2005535299A (en) |
| AT (1) | ATE403874T1 (en) |
| AU (1) | AU2003236645B2 (en) |
| CA (1) | CA2486738C (en) |
| CY (1) | CY1108358T1 (en) |
| DE (2) | DE10225139A1 (en) |
| DK (1) | DK1508047T3 (en) |
| ES (1) | ES2311710T3 (en) |
| IL (2) | IL165398A0 (en) |
| PT (1) | PT1508047E (en) |
| SI (1) | SI1508047T1 (en) |
| WO (1) | WO2003100432A2 (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008503498A (en) * | 2004-06-17 | 2008-02-07 | マンカインド コーポレイション | Tumor-associated antigen profiles in cancer diagnosis and immunotherapy |
| US9732131B2 (en) | 2006-02-27 | 2017-08-15 | Calviri, Inc. | Identification and use of novopeptides for the treatment of cancer |
| WO2007101227A2 (en) * | 2006-02-27 | 2007-09-07 | Arizona Board Of Regents For And On Behalf Of Arizona State University | Identification and use of novopeptides for the treatment of cancer |
| US20090004213A1 (en) * | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| GB201004551D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| GB201004575D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| GB201019331D0 (en) * | 2010-03-19 | 2010-12-29 | Immatics Biotechnologies Gmbh | Methods for the diagnosis and treatment of cancer based on AVL9 |
| GB201006360D0 (en) | 2010-04-16 | 2010-06-02 | Immatics Biotechnologies Gmbh | Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development |
| GB201423361D0 (en) | 2014-12-30 | 2015-02-11 | Immatics Biotechnologies Gmbh | Method for the absolute Quantification of naturally processed HLA-Restricted cancer peptides |
| DE102016123893A1 (en) | 2016-12-08 | 2018-06-14 | Immatics Biotechnologies Gmbh | T cell receptors with improved binding |
| EP4317432A3 (en) | 2016-12-08 | 2024-04-17 | Immatics Biotechnologies GmbH | T cell receptors with improved pairing |
| CA3065325A1 (en) | 2017-06-02 | 2018-12-06 | Arizona Board Of Regents On Behalf Of Arizona State University | A method to create personalized cancer vaccines |
| WO2019055618A1 (en) | 2017-09-15 | 2019-03-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods of classifying response to immunotherapy for cancer |
| DE102018122546B3 (en) | 2018-09-14 | 2019-12-05 | Immatics Biotechnologies Gmbh | High-throughput peptide MHC affinity screening method for TCR ligands |
| DE102019114735A1 (en) * | 2019-06-02 | 2020-12-03 | PMCR GmbH | Class I and II HLA tumor antigen peptides for the treatment of breast cancer |
| DE102019121007A1 (en) | 2019-08-02 | 2021-02-04 | Immatics Biotechnologies Gmbh | Antigen binding proteins that specifically bind to MAGE-A |
| US20210032370A1 (en) | 2019-08-02 | 2021-02-04 | Immatics Biotechnologies Gmbh | Recruiting agent further binding an mhc molecule |
| EP4038222A4 (en) | 2019-10-02 | 2023-10-18 | Arizona Board of Regents on behalf of Arizona State University | Methods and compositions for identifying neoantigens for use in treating and preventing cancer |
| EP4334361A1 (en) | 2021-05-05 | 2024-03-13 | Immatics Biotechnologies GmbH | Antigen binding proteins specifically binding prame |
| US20230057987A1 (en) | 2021-07-27 | 2023-02-23 | Immatics Biotechnologies Gmbh | Antigen binding proteins specifically binding ct45 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6156317A (en) * | 1996-11-12 | 2000-12-05 | City Of Hope | Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| DE10225144A1 (en) * | 2002-05-29 | 2003-12-18 | Immatics Biotechnologies Gmbh | Tumor-associated peptides binding to MHC molecules |
-
2002
- 2002-05-29 DE DE10225139A patent/DE10225139A1/en not_active Ceased
-
2003
- 2003-05-14 DK DK03735383T patent/DK1508047T3/en active
- 2003-05-14 AU AU2003236645A patent/AU2003236645B2/en not_active Expired
- 2003-05-14 WO PCT/EP2003/005038 patent/WO2003100432A2/en active IP Right Grant
- 2003-05-14 JP JP2004507838A patent/JP2005535299A/en active Pending
- 2003-05-14 PT PT03735383T patent/PT1508047E/en unknown
- 2003-05-14 AT AT03735383T patent/ATE403874T1/en active
- 2003-05-14 ES ES03735383T patent/ES2311710T3/en not_active Expired - Lifetime
- 2003-05-14 SI SI200331284T patent/SI1508047T1/en unknown
- 2003-05-14 IL IL16539803A patent/IL165398A0/en unknown
- 2003-05-14 DE DE50310283T patent/DE50310283D1/en not_active Expired - Lifetime
- 2003-05-14 CA CA2486738A patent/CA2486738C/en not_active Expired - Lifetime
- 2003-05-14 EP EP03735383A patent/EP1508047B1/en not_active Expired - Lifetime
-
2004
- 2004-11-25 IL IL165398A patent/IL165398A/en not_active IP Right Cessation
-
2008
- 2008-09-19 CY CY20081101021T patent/CY1108358T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003100432A3 (en) | 2004-06-03 |
| DE50310283D1 (en) | 2008-09-18 |
| AU2003236645B2 (en) | 2009-06-18 |
| SI1508047T1 (en) | 2008-12-31 |
| IL165398A (en) | 2013-04-30 |
| JP2005535299A (en) | 2005-11-24 |
| ATE403874T1 (en) | 2008-08-15 |
| CA2486738C (en) | 2011-07-12 |
| AU2003236645A1 (en) | 2003-12-12 |
| DE10225139A1 (en) | 2004-02-26 |
| CY1108358T1 (en) | 2014-02-12 |
| EP1508047B1 (en) | 2008-08-06 |
| DK1508047T3 (en) | 2008-10-20 |
| PT1508047E (en) | 2008-10-02 |
| EP1508047A2 (en) | 2005-02-23 |
| WO2003100432A2 (en) | 2003-12-04 |
| CA2486738A1 (en) | 2003-12-04 |
| ES2311710T3 (en) | 2009-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL165398A0 (en) | Method for identifying immunoreactive peptides | |
| WO2003089904A3 (en) | Aib1 as a prognostic marker and predictor of resistance to encocrine therapy | |
| AU2002347560A1 (en) | Data processing method | |
| WO2004050707A3 (en) | Tumor-specific recognition molecules | |
| WO2005058018A3 (en) | System and method for plant identification | |
| EP1090294A4 (en) | Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof | |
| ATE427127T1 (en) | BIOACTIVE COATING FOR MEDICAL DEVICE WITH KERATIN | |
| WO2004105574A3 (en) | Image guided radiation therapy | |
| EP1412388A4 (en) | Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin | |
| AU2001233913A1 (en) | Bcmp 84, a protein associated to breast cancer | |
| AU2001258373A1 (en) | Method for identifying helicobacter antigens | |
| WO2003073818A3 (en) | Proteomic analysis of tumors for development of consultative report of therapeutic options | |
| ATE427967T1 (en) | SPECIFIC ANTIBODIAL FRAGMENTS FOR THE HUMAN CARCINOEMBRYONIC ANTIGEN (CEA) | |
| WO2004047757A3 (en) | Diagnosing and treating hematopoietic cancers | |
| WO2003069553A3 (en) | Method of image analysis | |
| WO2020176461A3 (en) | Methods and compositions for treating neuroendocrine prostate cancer | |
| WO2001077290A3 (en) | Polynucleotides encoding novel secreted proteins | |
| WO2002024895A3 (en) | Transcription factors and zinc finger proteins | |
| SE9803962D0 (en) | Nucleic acid encoding a nervous tissue sodium channel | |
| EP1187336A3 (en) | Compression in the presence of shared data | |
| WO2004020452A3 (en) | Method for refolding neisserial nspa protein | |
| WO1998051782A3 (en) | Human 3-hydroxyisobutyryl-coenzyme a hydrolase | |
| DE50210890D1 (en) | AUTOMATIC IDENTIFICATION AND / OR VERIFICATION OF RICH TEXTURES SUCH AS FINGERPRINTS | |
| AU2002365104A1 (en) | Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof | |
| WO1998057986A3 (en) | Human preprotachykinin b |